IL-15 antagonists (Altor)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIL-15 antagonists (Altor)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-15 receptors antagonists
TargetsInterleukin-15 receptors
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltor Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltor Bioscience Corp
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A